Top Markets
#1 QuantixAI QuantixAI +102.94%
#2 龙虾 (Lobster) 龙虾 (Lobster) +29.51%
#3 MetaDAO MetaDAO +29.20%
#4 Rain Rain +24.16%
#5 DOG•GO•TO•THE•MOON (Runes) DOG•GO•TO•THE•MOON (Runes) +19.73%
#6 Bedrock Bedrock +19.11%
#7 Pons Pons +17.61%
#8 Prom Prom +16.34%
#9 Humanity Humanity +14.45%
#10 Ontology Gas Ontology Gas +14.45%
Coin of the day
QuantixAI QuantixAI
Instellingen
Taal
DUTCH
Valuta
USD
Thema
Chemical Works Chemical Works

Chemical Works

RICHT
Rang in aandelen #2662
Chemical Works of Gedeon Richter Plc engages in the development and manufacture... Chemical Works of Gedeon Richter Plc engages in the development and manufacture of pharmaceuticals. It operates through the following segments: Pharmaceuticals, Wholesale & Retail, and Others. The Pharmaceutical segment engages in research and development, manufacturing, sales and marketing of pharmaceutical products. The Wholesale & Retail segment represents the distribution of companies and pharmacies that are part of the sales network in various regional markets and, as such, convey its products to consumers. The Other segment relates to the business of the members of the group that provide marketing and sales support services. The company was founded by Gedeon Richter in 1901 and is headquartered in Budapest, Hungary.
Aandeelprijs
$41.81
Marktkapitalisatie
$7.65B
Verandering (1 dag)
0.23%
Verandering (1 jaar)
34.96%
Land
HU
Handel Chemical Works (RICHT)

Categorie

Healthcare
Winst voor Chemical Works (RICHT)
Winst in 2026 TTM: 0
Volgens de meest recente financiële verslagen van Chemical Works bedraagt de huidige winst van het bedrijf 0. In 2026 behaalde het bedrijf een winst van 0, gelijk aan de winst van 2026, die 0 bedroeg. De weergegeven winst op deze pagina is de winst vóór rente en belastingen, oftewel EBIT.
Winstgeschiedenis van Chemical Works van 2026 tot 2026
Winst aan het einde van elk jaar
Jaar Winst Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Winst van vergelijkbare bedrijven of concurrenten
Bedrijf Winst Winstverschil Land
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
$1.35B -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
- -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
- -
FR
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
$26.37M -
US
Sino Biopharmaceutical Limited Sino Biopharmaceutical Limited
Sino Biopharmaceutical Limited
1177.HK
$992.42M -
HK